GPCR Congress
G-protein-coupled receptors.
Our congress is working to become the single most focused site in the world dedicated to key technological and scientific trends in GPCR’s in the pharmaceutical and biotech industry. Additionally, we discuss potential legal issues such as personal injury resulting from bad drugs, or car accidents caused by a drug defect, as articles, news and progress reports from U.K., European, and American academic institutions.
Our online Proteins Congress also discusses G-protein coupled receptors that have proven to be a valuable target class is positive therapeutic intervention via small-molecule drugs. Since GPCRs represented approximately 25% of the total pharmaceutically-addressed drug targets, at the time of the writing of this page, these are the highest-druggable target family there is today. We are exploring the most efficient and employable technologies, strategies, and applications of GPCR in accelerating drug targeting.
This also applies to discovery and early development. Join the discussion in the UK, Europe and United States. This prestigious site provides a forum for practitioners, researchers like California injury attorneys, as well as consumers. To learn more about G-protein coupled receptors, and related spill over issues such as tort law, pain management, medical malpractice, bad drugs, chemistry safety and education issues check out our site.